Glypican-3 peptide reagents and methods
Abstract:
The present invention is directed to glypican-3-specific peptide reagents, methods for detecting hepatocellular carcinoma cells using the peptide reagents, and methods for targeting hepatocellular carcinoma cells using the peptide reagents.
Public/Granted literature
Information query
Patent Agency Ranking
0/0